Biospecifics Technologies (BSTC) Return on Equity ROE from the third quarter 2020 to third quarter 2019 and annually, average high and low, overall ranking from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Biospecifics Technologies Corp  (NASDAQ: BSTC)

Biospecifics Technologies's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Biospecifics Technologies in the third quarter 2020?
Biospecifics Technologies Corp achieved a return on average equity (ROE) of 13.39 % in its third quarter 2020, which is below Biospecifics Technologies's average return on equity, which stands at 20.94%.

ROE fell compared to the second quarter 2020, despite the net income growth of 4551.81% from the second quarter 2020.

Within the Major Pharmaceutical Preparations industry 31 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2020 from 713 to 825.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Equity Change 15.65 % 17.32 % 26.48 % 27.57 % -
Y / Y Net Income Change -14.13 % -98.2 % 1.86 % 18.92 % 24.39 %
Net Income (TTM) in Millions 17 18 25 24 23
Return On Equity (TTM) 13.39 % 14.59 % 20.41 % 21.56 % 21.82 %
BSTC's Total Ranking # 825 # 713 # 488 # 591 # 486
Equity (TTM) in Millions 135 129 129 124 117
Seq. Equity Change 4.56 % 0.11 % 3.84 % 6.4 % 6.07 %
Seq. Net Income Change 4551.81 % -97.43 % -38.82 % 17.23 % -2.39 %

Back to BSTC Management Effectiveness >> BSTC's 5 Years Annual ROE >> Compare BSTC ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 32
Sector # 103
Overall # 825

Return On Equity Statistics
High Average Low
26.11 %
20.94 %
13.39 %
(Dec 31 2013)   (Sep 30 2020)





BSTC Annual Return On Equity (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Equity in Millions 124 98 68 56 45
Y / Y Equity Change 27.57 % 44.54 % 19.96 % 25.6 % 48.1 %
Net Income in Millions 24 20 11 11 10
Y / Y Net Income Change 22.02 % 77.02 % -0.39 % 18.24 % 107.01 %
Return On Equity 19.66 % 20.55 % 16.78 % 20.21 % 21.46 %

Back to BSTC Management Effectiveness >> BSTC's 5 Years Annual ROE >> Compare BSTC ROE to its Competitors




Annual Roe Comment
In 2019 ROE fell to 19.66 %, despite net income growth.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BSTC's' Return on Equity at Yahoo Finance
BSTC's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BSTC's Competitors
Subscribers only: Roe for Biospecifics Technologies's Suppliers
Subscribers only: Return On Equity for BSTC's Customers




Companies with similar Return On Equity at Sep 30 2020, within Healthcare Sector ROE
Chemed Corporation  36.63 %
Pro dex Inc   34.24 %
Reflect Scientific Inc  33.28 %
Zynex inc   32.98 %
Siga Technologies Inc  31.83 %
Elite Pharmaceuticals Inc   30.50 %
Horizon Therapeutics Public Limited Company  30.08 %
Infusystem Holdings Inc  29.88 %
Regeneron Pharmaceuticals Inc   29.77 %
Pacira Biosciences inc   29.64 %
Lakeland Industries Inc   28.89 %
Resmed Inc   28.61 %
Johnson and Johnson  27.37 %
Prestige Consumer Healthcare Inc   27.16 %
Select Medical Holdings Corp  26.64 %
Royalty Pharma Plc  25.48 %
Corcept Therapeutics Inc  25.38 %
Boston Scientific Corporation  25.18 %
Biomarin Pharmaceutical Inc  24.96 %
Seagen Inc   24.50 %
Halozyme Therapeutics Inc   24.30 %
Amedisys Inc  23.92 %
Accuray Incorporated  22.56 %
Phibro Animal Health Corporation  21.89 %
Ensign Group Inc  21.66 %
Meridian Bioscience Inc   20.93 %
Supernus Pharmaceuticals inc   20.02 %
Healthcare Services Group Inc   19.82 %
Dexcom Inc   19.79 %
Edwards Lifesciences Corporation  19.73 %

Date modified: 2026-09-26T07:12:56+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.